This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in Store for Boston Properties (BXP) in Q2 Earnings?
by Zacks Equity Research
Boston Properties' (BXP) Q2 results are anticipated to reflect benefit from solid demand for its properties amid improving economy and job market gains. However, rising supply remains a concern.
Simon Property (SPG) to Post Q2 Earnings: What to Expect?
by Zacks Equity Research
Simon Property's (SPG) Q2 performance expected to display favorable impact of the company's efforts to beat retail blues by focusing on new development, redevelopment, expansion and acquisitions.
Will Favorable Demographic Trends Support UDR Q2 Earnings?
by Zacks Equity Research
UDR's Q2 results likely to reflect gains from favorable demographic trends, improvement in economy and job market gains. However, rising deliveries of new units remains a concern.
What's in Store for AvalonBay (AVB) This Earnings Season?
by Zacks Equity Research
AvalonBay (AVB) Q2 results likely to reflect benefits from favorable demographics and job growth. However, rising supply remains a drag.
Alexandria (ARE) Gears Up for Q2 Earnings: What to Expect?
by Zacks Equity Research
Alexandria Real Estate Equities (ARE) Q2 results will likely reflect the benefits from robust operating environment in the U.S office space. Nonetheless, non-core dispositions remain a drag.
Can Vornado (VNO) Maintain its Earnings Beat Streak in Q2?
by Zacks Equity Research
Vornado's (VNO) Q2 results are expected to reflect gains from strong fundamentals in the U.S office space. Further, its New York office portfolio performance will likely display decent figures.
Ventas (VTR) Gears Up for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Ventas' (VTR) Q2 performance expected to reflect favorable impact of the rising aging population as well as the company's strategic agreement with Brookdale.
Iron Mountain (IRM) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Iron Mountain's (IRM) Q2 performance will likely reflect the impact of intense competition in North America, as well as declining activity rates in the company's Services sector.
What's in the Cards for Kimco (KIM) This Earnings Season?
by Zacks Equity Research
Kimco Realty's (KIM) Q2 results will likely reflect the benefit of its portfolio-revamp efforts, progress on 2020 Vision, high consumer confidence and improving economy, despite an e-retail boom.
Key Factors to Impact Equity Residential (EQR) Q2 Earnings
by Zacks Equity Research
Equity Residential's (EQR) Q2 results are likely to gain from strong rental housing demand. However, higher supply is likely to dent growth.
Key Factors to Impact Digital Realty's (DLR) Q2 Earnings
by Zacks Equity Research
Digital Realty's (DLR) Q2 performance is likely to reflect impact of healthy industry fundamentals and strategic acquisitions. However, aggressive pricing pressure remains a drag.
Key Factors to Impact SL Green (SLG) Earnings This Season
by Zacks Equity Research
SL Green Realty's (SLG) Q2 results will likely reflect the company's efforts to reposition its portfolio through accretive acquisitions and non-core dispositions.
Crown Castle (CCI) to Report Q2 Earnings: What to Expect?
by Zacks Equity Research
Crown Castle International's (CCI) Q2 results likely to reflect benefits from a well-located tower portfolio. However, its top line might display impact of stiff competition in the industry.
HCP Might Sell Senior Housing Assets to Apollo for $428M
by Zacks Equity Research
HCP has been selling several of its seniors housing assets in a bid to improve the quality of the company's portfolio, strengthen balance sheet and lower the Brookdale operator concentration.
Will HCP's Endeavors to Revamp Portfolio be Sufficient?
by Zacks Equity Research
HCP's constant efforts to lower Brookdale concentration in its portfolio are aiding the company. However, the dilutive impact on earnings from the sale of assets is unavoidable.
HCP Revamps Portfolio Quality, Lowers Brookdale Concentration
by Zacks Equity Research
HCP's concerted efforts expected to improve portfolio quality, enhance operator diversification and strengthen balance sheet.
Why is HCP Up 1.9% Since Its Last Earnings Report?
by Zacks Equity Research
HCP reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Aimco's (AIV) Q1 FFO In Line With Estimates, Revenues Beat
by Zacks Equity Research
Apartment Investment and Management Company (AIV), better known as Aimco witness growth in property NOI in Q1 aided by same-store properties and lease-up of redevelopment and acquisition communities.
HCP's Q1 FFO and Revenues Beat Estimates, Reaffirms View
by Darshni Rupani
HCP Inc's (HCP) Q1 performance benefited from higher-than-expected revenue numbers for the quarter.
Why Earnings Season Could Be Great for HCP Inc. (HCP)
by Zacks Equity Research
HCP Inc. (HCP) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
Host Hotels (HST) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Host Hotels & Resorts (HST) Q1 results likely to reflect benefits from its portfolio of upscale hotels across potential markets and productivity gains, and impact of high supply and tough comparisons.
CBRE Group (CBRE) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
CBRE Group's (CBRE) Q1 results likely to reflect strength in regional services business and growth in global occupier outsourcing business.
Here's Why Hold Strategy is Apt for HCP Stock Right Now
by Darshni Rupani
HCP Inc. (HCP) has been continuously making efforts to lower Brookdale concentration from its portfolio but, the dilutive impact on earnings in the near term from the sale of assets is unavoidable.
HCP Vends Tandem Mezzanine Loan Investment for $112M
by Zacks Equity Research
In sync with its strategic measures, HCP (HCP) closes the sale of its mezzanine loan that was secured by interests in the Tandem Healthcare Portfolio for $112 million.
HCP Up 5.4% Since Earnings Report: Can It Continue?
by Zacks Equity Research
HCP reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.